Evidence that antipsychotic drugs are inverse agonists at D 2 dopamine receptors

British Journal of Pharmacology

Volumn 121, Issue 4, 1997, Pages 731-736

  Hall, David A ^a   Strange, Philip G ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Antipsychotic drugs; Dopamine receptors; Inverse agonism

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; BUTACLAMOL; CHLORPROMAZINE; CLOZAPINE; CYCLIC AMP; DOMPERIDONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; EMONAPRIDE; FLUPENTIXOL; FORSKOLIN; HALOPERIDOL; NEUROLEPTIC AGENT; PERTUSSIS TOXIN; RADIOLIGAND; SULPIRIDE;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIPSYCHOTIC AGENTS; BUTACLAMOL; CHO CELLS; CRICETINAE; CYCLIC AMP; DOPAMINE AGONISTS; FORSKOLIN; RECEPTORS, DOPAMINE D2;

EID: 0030912961     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701196     Document Type: Article

References (29)

1. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem., 269, 11687-11690.
2. 2-adrenoceptor. Nature, 374, 272-276.
3. 3 dopamine receptors to G-proteins. FEBS Lett., 315, 223-226.
4. 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. Biochemistry, 23, 4519-4525.
5. CHIDIAC, P., HEBERT, T.E., VALIQUETTE, M., DENNIS, M. & BOUVIER, M. (1993). Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol., 45, 490-499.
6. CIVELLI, O., BUNZOW, J.R. & GRANDY, D.K. (1993). Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol., 32, 281-307.
7. COSTA, T., LANG, J., GLESS, C. & HERZ, A. (1990). Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. Mol. Pharmacol., 37, 383-394.
8. FIBIGER, H.C. & GREWALL, D.S. (1974). Neurochemical evidence for denervation supersensitivity: the effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels. Life Sci., 15, 57-63.
9. L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther., 271, 1574-1582.
10. 2long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol., 118, 1544-1550.
11. GERFEN, C.R. (1992). The neostrialal mosaic. Annu. Rev. Neurosci., 15, 285-320.
12. B subtypes in a heterologous cell line. Mol. Endocrinol., 6, 920-926.
13. JOHANSSON, A.M., ARVIDSSON, L.E., HACKSELL, U., NILSSON, J.L.G., SVENSSON, K., HJORTH, S., CLARK, D., CARLSSON, A., SANCHEZ, D., ANDERSON, D. & WIKSTROM, H. (1985). Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. J. Med. Chem., 28, 1049-1053.
14. 3 receptors. Mol. Pharmacol., 43, 749-754.
15. MONTMAYER, J.P., GUIRAMAND, J. & BORRELLI, E. (1993). Preferential coupling between dopamine-D2 receptors and G-proteins. Mol. Endocrinol., 7, 161-170.
16. NILSSON, C.L. & ERIKSSON, F. (1993). Haloperidol increases prolactin release and cAMP formation in vitro inverse agonism at dopamine D2 receptors. J. Neural Trans., 92, 213-220.
17. OWEN, F., CROSS, A.J., CROW, T.J., LONGDEN, A., POULTER, M. & RILEY, G.J. (1978). Increased dopamine receptor sensitivity in schizophrenia. Lancet, ii, 223-226.
18. SCHÜTZ, W. & FREISSMUTH, M. (1992). Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci., 13, 376-380.
19. SEDVALL, G. & FARDE, L. (1995). Chemical brain anatomy in schizophrenia. Lancet, 346, 743-749.
20. SEEMAN, P. (1980). Brain dopamine receptors. Pharmacol. Rev., 32, 229-313.
21. SENOGLES, S.E. (1994). The D2 dopamine receptor isoforms signal through distinct Giα proteins to inhibit adenylyl cyclase - a study with site-directed mutant Giα proteins. J. Biol. Chem., 269, 23120-23127.
22. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
23. 3) as a target for neuroleptics. Nature, 347, 146-151.
24. STRANGE, P.G. (1992). Brain Biochemistry and Brain Disorders Oxford: Oxford University Press.
25. 3H]lisuride labels the free receptor and receptor coupled to G-protein. J. Neurochem., 65, 1909-1916.
26. 3H]spiperone to rat striatal preparation. J. Pharm. Pharmacol., 32, 441-444.
27. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol. Pharmacol., 45, 524-531.
28. TIBERI, M. & CARON, M.G. (1994). High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J. Biol. Chem., 269, 27925-27931.
29. 2 receptor. Trends Pharmacol. Sci., 10, 74-77.